Who owns Pharmacyclics?

Key details on Pharmacyclics (Ticker: PCYC)

Who owns Pharmacyclics?

Is PCYC a good stock to own? Find out who bought Pharmacyclics, who sold Pharmacyclics (PCYC) stock, and who holds a large position in Pharmacyclics.

Fund Name Number of Shares Share Valuation As Of
T. Rowe Price Associates 9.89M $1.21B Dec. 31, 2014
Baker Bros. Advisors 9.13M $1.12B Dec. 31, 2014
Ameriprise Financial 4.97M $607.49M Dec. 31, 2014
Janus Capital Management 4.88M $596.50M Dec. 31, 2014
Vanguard 3.63M $443.44M Dec. 31, 2014
PRIMECAP Management Company 2.31M $282.49M Dec. 31, 2014
OrbiMed Advisors 2.18M $32.29M Dec. 31, 2011
FMR 2.00M $235.40M Sept. 30, 2014
Capital World Investors^ 1.98M $242.62M Dec. 31, 2014
SUSQUEHANNA INTERNATIONAL 1.71M $201.11M Sept. 30, 2014
Visium Asset Management 1.68M $91.47M June 30, 2012
BlackRock Institutional Trust Company, N.A. 1.54M $187.74M Dec. 31, 2014
FRED ALGER MANAGEMENT 1.46M $146.80M March 31, 2014
BlackRock Fund Advisors 1.39M $169.93M Dec. 31, 2014
Columbus Circle Investors 1.36M $144.08M Dec. 31, 2013
GOLDMAN SACHS 1.34M $134.27M March 31, 2014
STATE STREET CORPORATION 1.14M $139.28M Dec. 31, 2014
QVT Financial 1.12M $16.58M Dec. 31, 2011
Franklin Resources 947900 $14.05M Dec. 31, 2011
S.A.C. Capital Advisors 939713 $99.40M Dec. 31, 2013
Bridger Management 900000 $13.34M Dec. 31, 2011
Barclays 895591 $94.04M Dec. 31, 2013

Who sold Pharmacyclics?

Fund Name Date Sold Number of Shares Sold Share Valuation
BVF Sept. 30, 2011 1.16M $13.70M
Balyasny Asset Management March 31, 2011 1.75M $10.28M
Sectoral Asset Management March 31, 2011 1.02M $5.98M
Perceptive Advisors Dec. 31, 2010 2.81M $17.07M